To understand the potential role of managed care organizations (MCOs) in prevention and control of sexually transmitted diseases (STDs), we conducted a systematic review of articles on STDs and managed care and sought qualitative information from MCOs on STD-related activities. The review focused on prevention, risk assessment, patient education, counseling, screening, and costs of care, but revealed relatively few published articles. Barriers to STD service delivery included competing priorities, lack of time or supporting organizational structures, and differing mandates of health departments and MCOs. Facilitators included collaboration between health departments and MCOs, regulatory and performance incentives, buy-in from key stakeholders, availability of infrastructure to support data collection, and inclusion of chlamydia screening in the Health Employer Data and Information Set to monitor plan performance. Because of the shift of STD service delivery from the public to private sector, incentives need to maximize interest and cooperation of patients, clinicians, and MCOs in STD prevention.
Cates W Jr.Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999;26(suppl 4):S2-S7.
2.
Koutsky LA, Holmes KK, Critchlow CW, et al.A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327: 1272-1278.
3.
Westrom L, Joesoef R, Reynolds G, et al.Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19:185-192.
4.
Marchbanks PA, Annegers JF, Coulam CB, et al.Risk factors for ectopic pregnancy. A population-based study. JAMA1988; 259:1823-1827.
5.
Workowski KA, Levine WC, Wasserheit JN. U.S. Centers for Disease Control and Prevention guidelines for the treatment of sexually transmitted diseases: an opportunity to unify clinical and public health practice. Ann Intern Med. 2002;137:255-262.
6.
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75:3-17.
7.
Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases?Fam Plann Perspect. 1999;31:10-15.
8.
Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2002. Atlanta, Ga: U.S. Department of Health and Human Services,2002. Table 2. Available at: http://www.cdc.gov/std/stats/tables/table2.htm. Accessed May 18, 2004.
9.
Centers for Medicare and Medicaid Services. National Summary of Medicaid Managed Care Programs and Enrollment: June 30, 2002. Available at: http://www.cms.hhs.gov/medicaid/managedcare/trendsO2.pdf. Accessed May 18, 2004.
10.
The Kaiser Family Foundation and Health Research and Educational Trust. Trends and indicators in the changing health care marketplace 2002. Available at: http://www.kff.org/insurance/loader.cfm?url=/commonspot/security/getfile.cfm&PageID=14967. Accessed May 18, 2004.
11.
Levi J. Managed care and public health. Am J Public Health. 2000;90:1823-1824.
12.
Salganicoff A, Delbanco SF. Medicaid and managed care: meeting the reproductive health needs of low-income women. J Public Health Manag Pract. 1998;4:13-22.
13.
Berg AO. Screening for chlamydia infection: recommendations and rationale. U.S. Preventive Services Task Force. Am J Nurs. 2002;102:87-92; discussion 93.
14.
U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed.1996. Available at: http://www.ahrq.gov/clinic/cpsix.htm. Accessed May 18, 2004.
15.
Bodenheimer T. The American health care system-the movement for improved quality in health care. N Engl J Med. 1999; 340:488-492.
16.
Burstein G, Snyder M, Conley D, et al.Screening females for Chlamydia trachomatis (CT) in a large managed care organization (MCO). A new HEDIS measure. J Pediatr Adolesc Gynecol. 2000;13:91.
17.
Dean Beaulieu N, Epstein AM. National Committee on Quality Assurance health-plan accreditation: predictors, correlates of performance, and market impact. Med Care. 2002;40:325-337.
18.
Scholes D, BlueSpruce J, Operskalski B, et al.The role of managed care in STD prevention and control: barriers, facilitators, and recommendations. American Association of Health Plans, 2001. Available at: httpI/www.aahp.org/internallinks/full-report5-26.pdf. Accessed May 18, 2004.
19.
Eng TR. Summary of workshop on the role of managed care organizations in STD prevention [Appendix G]. In: Institute of Medicine, The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press;1997.
20.
Gunn RA, Rolfs RT, Greenspan JR, et al.The changing paradigm of sexually transmitted disease control in the era of managed health care. JAMA. 1998;279:680-684.
21.
Rutherford GW. Public health, communicable diseases, and managed care: will managed care improve or weaken communicable disease control?Am J Prev Med. 1998;14(suppl 3):53-59.
22.
Platt R, Caldwell B. Can managed health care help manage health care-associated infections?Emerg Infect Dis. 2001;7: 358-362.
23.
Effler P, Ching-Lee M, Bogard A, Ieong MC, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA. 1999;282:1845-1850.
24.
Centers for Disease Control and Prevention. Reporting of laboratory-confirmed chlamydia infection and gonorrhea by providers affiliated with three large managed care organizations-United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51:256-259.
25.
Rutherford GW, Backer HD. Medicaid managed care and public health data. Public Health Rep. 1999;114:225-230.
26.
National Committee for Quality Assurance. Chlamydia screening. 2003. Washington, DC. Available at: http://www.ncqa.org/sohc2003/chlamydiascreening.htm. Accessed May 18, 2004.
27.
Gonen JS. Health plans and purchasers: managing women's primary care. Womens Health Issues. 1999;9(suppl 2):15S-25S.
28.
Drennan RB. Changes in the HMO marketplace and the new role of consumers. Benefits Q. 2000;16:45-53.
29.
Eng TR. Prevention of sexually transmitted diseases. A model for overcoming barriers between managed care and public health. The IOM Workshop on the Role of Health Plans in STD Prevention. Am J Prev Med. 1999;16:60-69.
30.
Brown ER, Nakashima J, Pourat N, et al.Delivery of Sexually Transmitted Disease Services in Medicaid Managed Care. Final Report. June 2000. Los Angeles: UCLA Center for Health Policy Research. Available at: http://www.healthpolicy.ucla.edulpubs/publication.asp?pubID=32. Accessed May 18, 2004.
31.
Chaulk CP, Zenilman J. Sexually transmitted disease control in the era of managed care: "magic bullet" or "shadow on the land"?J Public Health Manag Pract. 1997;3:61-70.
32.
Cates JR, Alexander L, Cates W Jr.Prevention of sexually transmitted diseases in an era of managed care: the relevance for women. Womens Health Issues. 1998;8:169-186; discussion 187-198.
33.
Ford CA, English A. Limiting confidentiality of adolescent health services: what are the risks?JAMA. 2002;288:752-753.
34.
Lafferty WE, Kimball AM, Bolan G, Handsfield HH. Medicaid managed care and STD prevention: opportunities and risks. J Public Health Manag Pract. 1998;4:52-58.
35.
Howell MR, Kassler WJ, Haddix A. Partner notification to prevent pelvic inflammatory disease in women. Cost-effectiveness of two strategies. Sex Transm Dis. 1997;24:287-292.
36.
Whittington WL, Kent C, Kissinger P, et al.Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis. 2001;28:117-123.
37.
St Lawrence JS, Montano DE, Kasprzyk D, et al.STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of U.S. physicians. Am J Public Health. 2002;92:1784-1788.
38.
Mauery DR, Rosenbaum S, Woolley SF, et al.An evaluation of emerging relationships through memoranda of understanding between managed care organizations and public health agencies: implications for population-based communicable disease prevention and control programs and public health policy. Washington, DC: George Washington University Medical Center, Center for Health Services Research and Policy,1998. Available at: http://www.gwhealthpolicy.org/downloads/moureport.pdf. Accessed May 18, 2004.
39.
U.S. Department of Health and Human Services, Public Health Service, Office of Public Health and Science, Office of Disease Prevention and Health Promotion. Clinician's Handbook of Preventive Services, 2nd ed.: Put Prevention into Practice. Washington, DC: U.S. Government Printing Office.1998. Available at: http://www.ahrq.gov/clinic/ppiphand.htm. Accessed May 18, 2004.
40.
Rosenbaum S, Kamoie B. Managed care and public health: conflict and collaboration. J Law Med Ethics. 2002;30:191-200.
41.
Civic D, Scholes D, Grothaus L, McBride C. Adolescent HMO enrollees' utilization of out-of-plan services. J Adolesc Health. 2001;28:491-496.
42.
Celum CL, Bolan G, Krone M, et al.Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis. 1997;24:599-605.
43.
Aral SO, Peterman TA. Do we know the effectiveness of behavioral interventions?Lancet. 1998;351(suppl 3):33-36.
44.
Scholes D, Anderson LA, Operskalski BH, et al.STD prevention and treatment guidelines: a review from a managed care perspective. Am J Manag Care. 2003;9:181-189.
45.
Shafer MA, Tebb KP, Pantell RH, et al.Effect of a clinical practice improvement intervention on chlamydial screening among adolescent girls. JAMA. 2002;288:2846-2852.
46.
Reid WM, Marshburn J, Siddharthan K. Managed care organizations and mammography: opportunities to serve underserved women. Women Health. 1999;28:13-28.
47.
Fairbrother G, Hanson KL, Butts GC, Friedman S. Comparison of preventive care in Medicaid managed care and Medicaid fee for service in institutions and private practices. Ambul Pediatr. 2001;1:294-301.
48.
Rein DB, Anderson LA, Gowda VR, et al.Federally funded sexually transmitted disease programs and managed care: a review of current and planned partnerships. Sex Transm Dis. 2001;28:336-342.
49.
Shapiro DW. Key issues in managed competition. West J Med. 1994;160:434-439.
50.
The Kaiser Family Foundation and Health Research and Educational Trust. State health facts online. Available at: http://www.statehealthfacts.kff.org/cgi-bin/healthfacts.cgi?action=compare&category=medicaid+%26+SCHIP&subcategory=Births+Financed+by+Medicaid&topic=Total+Medicaid+Births&link-category=&link-subcategory=&link-topic=&datatype=&printerfriendly=0&viewas=&showregions=0&sortby=region%23sorttop. Accessed May 18, 2004.
51.
Boekeloo BO, Schamus LA, Cheng TL, Simmens SJ. Young adolescents' comfort with discussion about sexual problems with their physician. Arch Pediatr Adolesc Med. 1996;150:1146-1152.
52.
Maheux B, Haley N, Rivard M, Gervais A. STD risk assessment and risk-reduction counseling by recently trained family physicians. Acad Med. 1995;70:726-728.
53.
Farquhar LJ, Stein T, Wagner D. Medical student knowledge levels and performance in doing HIV risk assessment. AIDS Educ Prey. 1995;7:469-476.
54.
Bull SS, Rietmeijer C, Fortenberry JD, et al.Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: results from the gonorrhea community action project (GCAP). Sex Transm Dis. 1999;26: 584-589.
55.
Schuster MA, Bell RM, Petersen LP, Kanouse DE. Communication between adolescents and physicians about sexual behavior and risk prevention. Arch Pediatr Adolesc Med. 1996;150: 906-913.
56.
Epstein RM, Morse DS, Frankel RM, et al.Awkward moments in patient-physician communication about HIV risk. Ann Intern Med. 1998;128:435-442.
57.
Boekeloo BO, Schamus LA, Simmens SJ, et al.A STD/HIV prevention trial among adolescents in managed care. Pediatrics. 1999;103:107-115.
58.
Millstein SG, Igra V, Gans J. Delivery of STD/HIV preventive services to adolescents by primary care physicians. J Adolesc Health. 1996;19:249-257.
59.
Kurth A, Bielinski L, Graap K, et al.Reproductive and sexual health benefits in private health insurance plans in Washington State. Fam Plann Perspect. 2001;33:153-160, 179.
60.
Sieving R, Resnick MD, Bearinger L, et al.Cognitive and behavioral predictors of sexually transmitted disease risk behavior among sexually active adolescents. Arch Pediatr Adolesc Med. 1997;151:243-251.
61.
Detzer MJ, Wendt SJ, Solomon LJ, et al.Barriers to condom use among women attending planned parenthood clinics. Women Health. 1995;23:91-102.
62.
Murphree DD, DeHaven MJ. Does grandma need condoms? Condom use among women in a family practice setting. Arch Fam Med. 1995;4:233-238.
63.
Reddy DM, Fleming R, Swain C. Effect of mandatory parental notification on adolescent girls' use of sexual health care services. JAMA. 2002;288:710-714.
64.
English A, Simmons PS. Legal issues in reproductive health care for adolescents. Adolesc Med. 1999;10:181-194.
65.
Branson BM, Peterman TA, Cannon RO, et al.Group counseling to prevent sexually transmitted disease and HIV: a randomized controlled trial. Sex Transm Dis. 1998;25:553-560.
66.
Kamb ML, Fishbein M, Douglas JM Jr, et al.Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. 1998;280:1161-1167.
67.
National Institute of Mental Health (NIMH). The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. Science. 1998;280:1889-1894.
68.
Jemmott JB III, Jemmott LS, Fong GT. Abstinence and safer sex HIV risk-reduction interventions for African American adolescents: a randomized controlled trial. JAMA. 1998;279:1529-1536.
69.
Scholes D, McBride CM, Grothaus L, et al.A tailored minimal self-help intervention to promote condom use in young women: results from a randomized trial. AIDS. 2003;17:1547-1556.
70.
BlueSpruce J, Dodge WT, Grothaus L, et al.HIV prevention in primary care: impact of a clinical intervention. AIDS Patient Care STDS. 2001;15:243-253.
71.
Dodge WT, BlueSpruce J, Grothaus L, et al.Enhancing primary care HIV prevention: a comprehensive clinical intervention. Am J Prev Med. 2001;20:177-183.
72.
Paperny DM. Computerized health assessment and education for adolescent HIV and STD prevention in health care settings and schools. Health Educ Behau1997;24:54-70.
73.
Schechtel J, Coates T, Mayer K, Makadon H. HIV risk assessment: physician and patient communication. J Gen Intern Med. 1997;12:722-723.
74.
Barton SE, Munday PE, Patel RJ. Asymptomatic shedding of herpes simplex virus from the genital tract: uncertainty and its consequences for patient management. The Herpes Simplex Virus Advisory Panel [editorial]. Int J STD AIDS. 1996;7:229-232.
75.
American College of Obstetricians and Gynecologists (ACOG) Committee Opinion. Condom availability for adolescents. American College of Obstetricians and Gynecologists. JAdolesc Health. 1996;18:380-383.
76.
American Academy of Pediatrics. Condom availability for youth. Committee on Adolescence, American Academy of Pediatrics. Pediatrics. 1995;95:281-285.
77.
Council on Long Range Planning and Development. AMA Policy Compendium. Chicago, Ill: American Medical Association;1990.
78.
American College of Obstetricians and Gynecologists. ACOG Statement of Policy: Confidentiality in Adolescent Health Care. Washington, DC: American College of Obstetricians and Gynecologists;1988.
79.
Han Y, Coles FB, Hipp S. Screening criteria for Chlamydia trachomatis in family planning clinics: accounting for prevalence and clients' characteristics. Pam Plann Perspect. 1997;29: 163-166.
80.
Handsfield HH. Screening asymptomatic women for Chlamydia trachomatis: abstract and commentary. JAMA. 1998;280: 1800-1801.
81.
Marrazzo JM, Fine D, Celum CL, et al.Selective screening for chlamydia infection in women: a comparison of three sets of criteria. Pam Plann Perspect. 1997;29:158-162.
82.
Mertz KJ, Levine WC, Mosure DJ, et al.Screening women for gonorrhea: demographic screening criteria for general clinical use. Am J Public Health. 1997;87:1535-1538.
83.
Mertz KJ, Levine WC, Mosure DJ, et al.Trends in the prevalence of chlamydia infections. The impact of community-wide testing. Sex Transm Dis. 1997;24:169-175.
84.
Scholes D, Stergachis A, Heidrich FE, et al.Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Engl J Med. 1996;334:1362-1366.
85.
Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections-United States, 1995. MMWR Morb Mortal Wkly Rep. 1997;46:193-198.
86.
Casebeer L, Allison J, Spettell CM. Designing tailored web-based instruction to improve practicing physicians' chlamydia screening rates. Acad Med. 2002;77:929.
87.
Thrall JS, McCloskey L, Spivak H, et al.Performance of Massachusetts HMOs in providing Pap smear and sexually transmitted disease screening to adolescent females. J Adolesc Health. 1998;22:184-189.
88.
Marrazzo JM, White CL, Krekeler B, et al.Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med. 1997;127:796-803.
89.
Oh MK, Richey CM, Pate MS, et al.High prevalence of Chlamydia trachomatis infections in adolescent females not having pelvic examinations: utility of PCR-based urine screening in urban adolescent clinic setting. J Adolesc Health. 1997;21:80-86.
90.
Lafferty WE, Downey L, Holan CM, et al.Provision of sexual health services to adolescent enrollees in Medicaid managed care. Am J Public Health. 2002;92:1779-1783.
91.
Marrazzo JM, Stamm WE. New approaches to the diagnosis, treatment, and prevention of chlamydia infection. Curr Clin Top Infect Dis. 1998;18:37-59.
92.
Nelson HD, Helfand M. Screening for chlamydia infection. Am J Prev Med. 2001;20(suppl 3):95-107.
93.
Teran S, Walsh C, Irwin KL. Chlamydia trachomatis infection in women: bad news, good news, and next steps in prevention. JAm Med Womens Assoc. 2001;56:100-104.
94.
Ratelle S, Yokoe D, Whelan M, et al.Management of urethritis in health maintenance organization members receiving care at a multispecialty group practice in Massachusetts. Sex Transm Dis. 2001;28:232-235.
95.
Schauffler HH, Chapman SA. Health promotion and managed care: surveys of California's health plans and population. Am J Prev Med. 1998;14:161-167.
96.
Davis K, Collins KS, Schoen C, et al.Choice matters: enrollees' views of their health plans. Health Aff (Millwood). 1995;14:99-112.
97.
Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect. 1998; 74:66-70.
98.
Coffield AB, Maciosek MV, McGinnis JM, et al.Priorities among recommended clinical preventive services. Am J Prey Med. 2001;21:1-9.
99.
Mangione-Smith EJ, O'Leary J, McGlynn EA. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis. 1999;26:309-316.
100.
Marrazzo JM, Celum CL, Hillis SD, et al.Performance and cost effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis. 1997;24:131-141.
101.
Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for Chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transm Dis. 1998;25:108-117.
102.
Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med. 1998;128:277-284.
103.
Genc M, Mardh A. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med. 1996;124:1-7.
104.
Paavonen J. Is screening for Chlamydia trachomatis infection cost effective?Genitourin Med. 1997;73:103-104.
105.
Rein DB, Kassler WJ, Irwin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol. 2000;95:397-402.
106.
Yeh JM, Hook EW III, Goldie SJ. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis. 2003;30:369-378.
107.
Boekeloo BO, Snyder MH, Bobbin M, et al.Provider willingness to screen all sexually active adolescents for chlamydia. Sex Transm Infect. 2002;78:369-373.
108.
Kacena KA, Quinn SB, Hartman SC, et al.Pooling of urine samples for screening for Neisseria gonorrhoeae by ligase chain reaction: accuracy and application. J Clin Microbiol. 1998;36: 3624-3628.
109.
Aseltyne WJ, Cloutier M, Smith MD. HIV disease and man-aged care: an overview. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(suppl 1):S11-S22.
110.
Holman PB, Harris JR, Jones WK. Managed care-issues and opportunities: a view from the CDC. J Am Med Womens Assoc. 1997;52:85-88.
111.
Croughan-Minihane MS, Thom DH, Petitti DB. Research interests of physicians in two practice-based primary care research networks. West J Med. 1999;170:19-24.
112.
Bodenheimer T. The American health care system-physicians and the changing medical marketplace. N Engl J Med. 1999; 340:584-588.
113.
McLaughlin CP. Managed care and its relationship to public health barriers and opportunities. In: Halverson PK, Kazulny AD, McLaughlin CP, Mays GP, eds. Managed Care & Public Health. Gaithersburg, Md: Aspen Publishers, Inc;1998:42-72.
Pourat N, Brown ER, Razack N, Kassler W. Medicaid managed care and STDs: missed opportunities to control the epidemic. Health Aff (Millwood). 2002;21:228-239.
116.
Solanki G, Schauffler HH. Cost-sharing and the utilization of clinical preventive services. Am J Preu Med. 1999;17:127-133.
117.
Stewart J. Permanente Joins Campaign for Consumer Protection. The Permanente Journal. Fall 1997. Available at: http://xnet.kp.org/permanentejournal/fall97pj/campaign.html. Accessed May 18, 2004.
118.
Centers for Medicare & Medicaid Services. Physician group practice demonstration. Available at: http://cms/hhs.gov/healthplans/research/pgpdemo.asp? Accessed May 18, 2004.
119.
Cates JR, Cates W Jr.STD prevention in the United States. Lessons from history for the new millennium. Am J Preu Med. 1999;16:75-77.
120.
Stein Z. Family planning, sexually transmitted diseases, and the prevention of AIDS-divided we fail?Am J Public Health. 1996;86:783-784.
121.
Gonen JS. Confronting STDs: a challenge for managed care. Womens Health Issues. 1999;9:36S-46S.
122.
Hillman AL. The impact of physician financial incentives on high-risk populations in managed care. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(suppl 1):S23-S30.
123.
Amonkar MM, Madhavan S, Rosenbluth SA, Simon KJ. Barriers and facilitators to providing common preventive screening services in managed care settings. J Community Health. 1999; 24:229-247.
